| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |